- Home
- LIN vs PFE Comparison
LIN vs PFE Comparison
Compare LIN & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIN | PFE |
|---|---|---|
| Founded | 1879 | 1849 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.7B | 155.2B |
| IPO Year | 2017 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LIN | PFE |
|---|---|---|
| Price | $498.71 | $27.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $526.00 | $28.92 |
| AVG Volume (30 Days) | 2.1M | ★ 28.3M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | 1.21% | ★ 6.33% |
| EPS Growth | ★ 7.27 | N/A |
| EPS | ★ 14.61 | 1.36 |
| Revenue | $33,986,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $5.56 | N/A |
| Revenue Next Year | $4.91 | N/A |
| P/E Ratio | $34.09 | ★ $20.00 |
| Revenue Growth | ★ 2.97 | N/A |
| 52 Week Low | $387.78 | $21.87 |
| 52 Week High | $510.32 | $28.75 |
Technical Indicators
Market Signals| Indicator | LIN | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 53.66 | 49.80 |
| Support Level | $476.72 | $26.34 |
| Resistance Level | $500.34 | $27.70 |
| Average True Range (ATR) | 8.95 | 0.55 |
| MACD | -0.31 | -0.07 |
| Stochastic Oscillator | 61.81 | 28.33 |
Price Performance
Historical ComparisonAbout LIN Linde plc
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $34 billion in revenue in 2025.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.